$IPXL Headlines Best Buy tops SP 500; Netflix sn

$IPXL Headlines

Best Buy tops S&P 500; Netflix snaps losing streak 3:21 p.m. Oct. 10, 2013 - Sue Chang
Citrix, Ruby Tuesday shares fall after hours 4:06 p.m. Oct. 9, 2013 - Wallace Witkowski
Supreme Court decision on generics hits Actavis, but few other drug firms 11:46 a.m. June 17, 2013 - Russ Britt
Tuesday’s movers: Cisco propels Dow to new record 4:16 p.m. March 5, 2013 - Sue Chang
Stocks poised to top all-time closing high 9:23 a.m. March 5, 2013 - Kate Gibson
J.C. Penney, Impax shares drop after hours 6:46 p.m. March 4, 2013 - Carla Mozee
Impax: FDA finds continuing problems at plant 5:49 p.m. March 4, 2013 - MarketWatch.com
Impax shares resume trading, drop 19% 4:43 p.m. March 4, 2013 - Carla Mozee
An orderly pullback from multi-year highs 9:47 a.m. Sept. 20, 2012 - Michael Ashbaugh
Europe stock swoon deepens after U.S. data 11:11 a.m. Sept. 4, 2012 - Sara Sjolin
Shire sinks on generic Adderall approval 2:38 a.m. July 10, 2012 - MarketWatch.com
Stocks to watch Monday: Shire, Kirby, Tesla 5:59 a.m. June 25, 2012 - MarketWatch
Charting the 2012 uptrend 9:53 a.m. April 2, 2012 - Michael Ashbaugh
Nasdaq works off major technical breakout 11:00 a.m. Feb. 6, 2012 - Michael Ashbaugh
Impax jumps 10% on Parkinson's study 11:47 a.m. Aug. 15, 2011 - Val Brickates Kennedy
Impax leads drug stocks lower 1:05 p.m. June 8, 2011 - Val Brickates Kennedy
Ten decliners in Wednesday's market 9:50 a.m. June 8, 2011 - Tom Bemis
Impax drops 11% on downgrade 9:20 a.m. June 8, 2011 - Val Brickates Kennedy
Impax gets FDA warning letter for plant issues 7:11 a.m. June 6, 2011 - MarketWatch.com
S&P 500 holds tightly to the January peak 10:09 a.m. Jan. 26, 2011 - Michael Ashbaugh


Impax Laboratories Inc. Stock Upgraded (IPXL) 10:14 a.m. Dec. 6, 2013 - TheStreet.com
Impax Settles Litigation with Purdue Pharma - Analyst Blog 6:32 p.m. Dec. 5, 2013 - Zacks.com
Impax Labs Attains 52-Week High - Analyst Blog 2:11 p.m. Dec. 2, 2013 - Zacks.com
Short Interest Drops 28% For IPXL 4:19 p.m. Nov. 27, 2013 - TheStreet.com
Bull Of The Day: Impax 3:12 p.m. Nov. 27, 2013 - Seeking Alpha
Bull of the Day: Impax (IPXL) - Bull of the Day 5:06 a.m. Nov. 27, 2013 - Zacks.com
Impax Launches Generic Solaraze - Analyst Blog 5:30 p.m. Nov. 22, 2013 - Zacks.com
Actavis Cuts 350 Sales Positions in the U.S. - Analyst Blog 11:50 a.m. Nov. 22, 2013 - Zacks.com
Simcere Reports a Loss - Analyst Blog 1:57 p.m. Nov. 18, 2013 - Zacks.com
Akorn (AKRX) In Focus: Stock Jumps 8.1% - Tale of the Tape 9:11 a.m. Nov. 18, 2013 - Zacks.com
Anacor Rises on Positive Data - Analyst Blog 4:45 p.m. Nov. 14, 2013 - Zacks.com
Insider Trading Alert - IPXL, IPI, DNKN, PMTC And LRN Traded By Insiders 1:01 p.m. Nov. 14, 2013 - TheStreet.com
Narrow-than-Expected Loss at Pernix - Analyst Blog 10:20 a.m. Nov. 14, 2013 - Zacks.com
Actelion's Opsumit Cleared in Canada - Analyst Blog 5:00 p.m. Nov. 13, 2013 - Zacks.com
Narrower Q3 Loss at Supernus - Analyst Blog 1:33 p.m. Nov. 13, 2013 - Zacks.com
UPDATE: Janney Capital Markets Initiates Coverage on Impax Laboratories as The Last Mid-Cap Generics Company Standing 7:38 a.m. Nov. 13, 2013 - benzinga.com
Will Teva Pharmaceuticals Overcome Its Patent Cliff Worries? 6:22 p.m. Nov. 12, 2013 - Seeking Alpha
Mallinckrodt Misses on Earnings & Sales - Analyst Blog 2:07 p.m. Nov. 12, 2013 - Zacks.com
Arena Pharmaceuticals (ARNA) Worth Watching: Stock Surges 17.4% - Analyst Blog 9:02 a.m. Nov. 11, 2013 - Zacks.com
Impax Earnings Fall on Lower Revenues - Analyst Blog 12:20 p.m. Nov. 5, 2013 - Zacks.com


Upcoming Presentations, Stock Price Movements, and Patent Challenge Settlements - Research Report on Johnson & Johnson, Alexion, Intuitive Surgical, Medivation, and Impax 8:00 a.m. Dec. 6, 2013 - PR Newswire
Purdue Pharma L.P. Announces Resolution of OxyContin® (oxycodone HCl controlled-release) Tablets CII Patent Lawsuit with Impax Laboratories, Inc. 8:09 a.m. Dec. 3, 2013 - PR Newswire
Impax Laboratories Announces OxyContin(R) Patent Challenge Settlement 8:00 a.m. Dec. 3, 2013 - BusinessWire
Impax Laboratories to Present at the 25th Annual Piper Jaffray Healthcare Conference on December 3 8:30 a.m. Nov. 27, 2013 - BusinessWire
Grants and Stock Movements of Major Drug Manufacturers - Research Report on AbbVie, Keryx Biopharmaceuticals, Pacira Pharmaceuticals, Rockwell Medical, and Impax Laboratories 8:00 a.m. Nov. 22, 2013 - PR Newswire
Impax Laboratories Launches Generic Solaraze(R) (Diclofenac Sodium Gel, 3%) 8:45 a.m. Nov. 21, 2013 - BusinessWire
Pre-Market Review: Star Scientific Inc., Pharmacyclics Inc., United Therapeutics Corp., and Impax Laboratories Inc. 8:19 a.m. Nov. 21, 2013 - PR Newswire
Extension Study Data, Financial Results, Scheduled Conferences and Presentations - Research Report on Keryx, Raptor, Pacira, Horizon Pharma, and Impax 8:00 a.m. Nov. 13, 2013 - PR Newswire
Impax Laboratories to Present at the 2013 Credit Suisse Healthcare Conference on November 14 9:00 a.m. Nov. 7, 2013 - BusinessWire
Conference Call Schedules, Presentations, Collaborations and FDA Approvals - Research Report on Pharmacyclics, Pacira Pharmaceuticals, Raptor Pharmaceuticals, Impax Laboratories, and AcelRx 8:00 a.m. Nov. 6, 2013 - PR Newswire
Impax Laboratories Reports Third Quarter 2013 Results 4:01 p.m. Nov. 4, 2013 - BusinessWire
Under AAAResearchReports.com Microscope: Star Scientific Inc., Pharmacyclics Inc., Impax Laboratories Inc., and United Therapeutics Corp. 8:18 a.m. Oct. 30, 2013 - PR Newswire
Impax Laboratories and TOLMAR, Inc. Announce Final FDA Approval for Generic Solaraze(R) Gel (Diclofenac Sodium-3%) 6:30 a.m. Oct. 30, 2013 - BusinessWire
Impax Laboratories Confirms Patent Challenge Relating to Generic Atelvia(R) Delayed-Release Tablets, 35 mg 7:00 a.m. Oct. 25, 2013 - BusinessWire
Today's Research: Pharmacyclics Inc., United Therapeutics Corp., Star Scientific Inc., and Impax Laboratories Inc. 8:22 a.m. Oct. 8, 2013 - PR Newswire
Impax Laboratories Schedules Conference Call and Webcast for Third Quarter 2013 Financial Results 8:00 a.m. Oct. 8, 2013 - BusinessWire
Up to Sixty Percent of Surveyed U.S. Managed Care Organization Directors Expect to Cover Key Emerging Therapies for Parkinson's Disease on Their Largest Commercial Plan 9:00 a.m. Aug. 19, 2013 - PR Newswire
Impax Laboratories to Present at the Canaccord Genuity Annual Growth Conference 8:00 a.m. Aug. 13, 2013 - BusinessWire
RDInvesting Provides Investors with Free In-Depth Equity Reports on ABBV, IPXL, OMED and XOMA 7:51 a.m. Aug. 13, 2013 - ACCESSWIRE
Impax Laboratories Reports Second Quarter 2013 Results 3:02 p.m. Aug. 8, 2013 - BusinessWire